Maria A. Barbera, Ph.D. - Related publications

Affiliations: 
2007 Genetics & Molecular Biology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Genetics
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Talwelkar SS, Mäyränpää MI, Søraas L, Potdar S, Bao J, Hemmes A, Linnavirta N, Lømo J, Räsänen J, Knuuttila A, Wennerberg K, Verschuren EW. Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments. Cell Reports. Medicine. 2: 100373. PMID 34467250 DOI: 10.1016/j.xcrm.2021.100373   
2021 Chen CC, Chen CY, Cheng SF, Shieh TM, Leu YL, Chuang WY, Liu KT, Ueng SH, Shih YH, Chou LF, Wang TH. Hydroxygenkwanin Increases the Sensitivity of Liver Cancer Cells to Chemotherapy by Inhibiting DNA Damage Response in Mouse Xenograft Models. International Journal of Molecular Sciences. 22. PMID 34575923 DOI: 10.3390/ijms22189766   
2021 Sato D, Moriya K, Nakano T, Miyagawa C, Katayama S, Niizuma H, Sasahara Y, Kure S. Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia-telangiectasia caused by novel compound heterozygous variants in ATM. International Journal of Hematology. PMID 34424493 DOI: 10.1007/s12185-021-03203-w   
2021 Liu A, Zhou K, Martínez MA, Lopez-Torres B, Martínez M, Martínez-Larrañaga MR, Wang X, Anadón A, Ares I. A "Janus" face of the RASSF4 signal in cell fate. Journal of Cellular Physiology. PMID 34553373 DOI: 10.1002/jcp.30592   
2021 Yue E, Yang G, Yao Y, Wang G, Mohanty A, Fan F, Zhao L, Zhang Y, Mirzapoiazova T, Walser TC, Rodriguez-Rodriguez L, Fong Y, Salgia R, Wang EW. Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment. Cancers. 13. PMID 34503075 DOI: 10.3390/cancers13174265   
2021 Boldrini L, Faviana P, Galli L, Paolieri F, Erba PA, Bardi M. Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database. Genes. 12. PMID 34573332 DOI: 10.3390/genes12091350   
2021 Song L, Qi S, Hu W, Fang Z, Yu D, Liu T, Wu J, Wu Y, Wu A, Feng L, Xie J, Zhang B, He W, Ning Z, Liu L, et al. Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer. Molecular Therapy. Nucleic Acids. 26: 11-21. PMID 34513290 DOI: 10.1016/j.omtn.2021.06.015   
2021 Bagheri-Yarmand R, Busaidy NL, McBeath E, Danysh BP, Evans KW, Moss TJ, Akcakanat A, Ng PKS, Knippler CM, Golden JA, Williams MD, Multani AS, Cabanillas ME, Shaw KR, Meric-Bernstam F, et al. Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient. Cancers. 13. PMID 34638434 DOI: 10.3390/cancers13194950   
2021 Yim SY, Lee JS. An Overview of the Genomic Characterization of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 8: 1077-1088. PMID 34522690 DOI: 10.2147/JHC.S270533   
2021 Marijon H, Gery S, Chang H, Landesman Y, Shacham S, Lee DH, de Gramont A, Koeffler HP. Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status. Oncotarget. 12: 1749-1762. PMID 34504648 DOI: 10.18632/oncotarget.28047   
2021 Shao Q, Wang L, Yuan M, Jin X, Chen Z, Wu C. TIGIT Induces (CD3+) T Cell Dysfunction in Colorectal Cancer by Inhibiting Glucose Metabolism. Frontiers in Immunology. 12: 688961. PMID 34659197 DOI: 10.3389/fimmu.2021.688961   
2021 Zhuang Y, Ma Y, Yan S, Zhao B, Wu S, Zhang Q, Huang X, Zhao H, Zhao C, Liu Z, Yang L. Cyy260, a novel small molecule inhibitor, suppresses non-small cell lung cancer cell growth via JAK2/STAT3 pathway. American Journal of Cancer Research. 11: 4241-4258. PMID 34659885   
2021 Xavier MA, Rezende F, Titze-de-Almeida R, Cornelissen B. BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme. Biomolecules. 11. PMID 34439854 DOI: 10.3390/biom11081188   
2021 Melo CM, Vidotto T, Chaves LP, Lautert-Dutra W, Reis RBD, Squire JA. The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer. International Journal of Molecular Sciences. 22. PMID 34502458 DOI: 10.3390/ijms22179550   
2021 Chang Y, Wang Y, Li B, Lu X, Wang R, Li H, Yan B, Gu A, Wang W, Huang A, Wu S, Li R. Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer. Frontiers in Genetics. 12: 722078. PMID 34616428 DOI: 10.3389/fgene.2021.722078   
2021 Liu PF, Shu CW, Lee CH, Sie HC, Liou HH, Cheng JT, Ger LP, Chen CL, Chen CC, Chen CF. Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma. Cancers. 13. PMID 34439200 DOI: 10.3390/cancers13164043   
2021 Ozkayalar H, Ergoren MC, Tuncel G, Kurt S, Cevik E, Ozemri Sag S, Yilmaz Ozguven B, Kabukcuoglu F, Mocan G, Temel ŞG. Mutation Status and Immunohistochemical Correlation of Mutations in Gastrointestinal Stromal Tumors. Balkan Journal of Medical Genetics : Bjmg. 24: 67-72. PMID 34447661 DOI: 10.2478/bjmg-2021-0006   
2021 Xu J, Shen Y, Wang C, Tang S, Hong S, Lu W, Xie X, Cheng X. Arsenic compound sensitizes homologous recombination proficient ovarian cancer to PARP inhibitors. Cell Death Discovery. 7: 259. PMID 34552062 DOI: 10.1038/s41420-021-00638-2   
2021 Loneker AE, Wells RG. Perspective: The Mechanobiology of Hepatocellular Carcinoma. Cancers. 13. PMID 34503085 DOI: 10.3390/cancers13174275   
2021 Bashash D, Zandi Z, Kashani B, Pourbagheri-Sigaroodi A, Salari S, Ghaffari SH. Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities. Journal of Cellular Physiology. PMID 34498289 DOI: 10.1002/jcp.30575   
2021 Kanwore K, Kambey PA, Guo XX, Abiola AA, Xia Y, Gao D. Extracellular and Intracellular Factors in Brain Cancer. Frontiers in Cell and Developmental Biology. 9: 699103. PMID 34513834 DOI: 10.3389/fcell.2021.699103   
2021 Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sei A, Sugaya J, Iwata S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma. Human Cell. PMID 34535876 DOI: 10.1007/s13577-021-00612-1   
2021 Xiao P, Chen P, Lang X, An Q, Yang C, Chen S, Wang K, Chen N, Hao Y, Ding J, Li Z, Hu S, Xiao S. Ovarian germ cell tumor/mastocytosis with KIT mutation: a unique clinicopathological entity. Genes, Chromosomes & Cancer. PMID 34553465 DOI: 10.1002/gcc.23000   
2021 Tanaka K, Asahina H, Kishimoto J, Miyata Y, Uchida T, Watanabe K, Hamai K, Harada T, Tsubata Y, Sugawara S, Kobayashi K, Sugio K, Oizumi S, Okamoto I. Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial. European Journal of Cancer (Oxford, England : 1990). 149: 14-22. PMID 33813328 DOI: 10.1016/j.ejca.2021.02.019   
2021 Azwar S, Seow HF, Abdullah M, Faisal Jabar M, Mohtarrudin N. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology. 10. PMID 34571731 DOI: 10.3390/biology10090854   
2021 Stone NE, Raj A, Young KM, DeLuca AP, Chrit FE, Tucker BA, Alexeev A, McDonald J, Benigno BB, Sulchek T. Label-free microfluidic enrichment of cancer cells from non-cancer cells in ascites. Scientific Reports. 11: 18032. PMID 34504124 DOI: 10.1038/s41598-021-96862-y   
2021 Chan WY, Brown LJ, Reid L, Joshua AM. PARP Inhibitors in Melanoma-An Expanding Therapeutic Option? Cancers. 13. PMID 34572747 DOI: 10.3390/cancers13184520   
2021 Gandhi NS, Wang E, Sorolla A, Kan YJ, Malik A, Batra J, Young KA, Tie WJ, Blancafort P, Mancera RL. Design and Characterization of a Cell-Penetrating Peptide Derived from the SOX2 Transcription Factor. International Journal of Molecular Sciences. 22. PMID 34502261 DOI: 10.3390/ijms22179354   
2021 Castro J, Tornillo G, Ceada G, Ramos-Neble B, Bravo M, Ribó M, Vilanova M, Smalley MJ, Benito A. A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells. Cancers. 13. PMID 34503160 DOI: 10.3390/cancers13174350   
2021 Liguori NR, Lee Y, Borges W, Zhou L, Azzoli C, El-Deiry WS. Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies. Frontiers in Pharmacology. 12: 747180. PMID 34531756 DOI: 10.3389/fphar.2021.747180   
2021 Waldschmidt JM, Kloeber JA, Anand P, Frede J, Kokkalis A, Dimitrova V, Potdar S, Nair MS, Vijaykumar T, Im NG, Guillaumet-Adkins A, Chopra N, Stuart H, Budano L, Sotudeh N, et al. Single-cell profiling reveals metabolic reprogramming as a resistance mechanism in BRAF-mutated multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34518309 DOI: 10.1158/1078-0432.CCR-21-2040   
2021 Shalata W, Jacob BM, Agbarya A. Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future. Cancers. 13. PMID 34439273 DOI: 10.3390/cancers13164119   
2021 Minari R, Leonetti A, Gnetti L, Zielli T, Ventura L, Bottarelli L, Lagrasta C, La Monica S, Petronini PG, Alfieri R, Tiseo M. Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib. Anti-Cancer Drugs. 32: 758-762. PMID 33675607 DOI: 10.1097/CAD.0000000000001064   
2021 Robinson PS, Coorens THH, Palles C, Mitchell E, Abascal F, Olafsson S, Lee BCH, Lawson ARJ, Lee-Six H, Moore L, Sanders MA, Hewinson J, Martin L, Pinna CMA, Galavotti S, et al. Increased somatic mutation burdens in normal human cells due to defective DNA polymerases. Nature Genetics. 53: 1434-1442. PMID 34594041 DOI: 10.1038/s41588-021-00930-y   
2021 Cheradame L, Guerrera IC, Gaston J, Schmitt A, Jung V, Goudin N, Pouillard M, Radosevic-Robin N, Modesti M, Judde JG, Cairo S, Goffin V. STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway. Oncogene. PMID 34625708 DOI: 10.1038/s41388-021-02037-4   
2021 Bayir Garbioglu D, Demir N, Ozel C, Avci H, Dincer M. Determination of therapeutic agents efficiencies of microsatellite instability high colon cancer cells in post-metastatic liver biochip modeling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21834. PMID 34403553 DOI: 10.1096/fj.202100333R   
2021 Tavares FM, Gomes AC, Assunção EM, de Medeiros JLS, Scotti MT, Scotti L, Ishiki HM. Virtual Screening and Molecular Docking: Discovering Novel c-KIT Inhibitors. Current Medicinal Chemistry. PMID 34525909 DOI: 10.2174/0929867328666210915102920   
2021 Cui Y, Li H, Zhan H, Han T, Dong Y, Tian C, Guo Y, Yan F, Dai D, Liu P. Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical Characteristics. Frontiers in Oncology. 11: 733478. PMID 34604069 DOI: 10.3389/fonc.2021.733478   
2021 Notarstefano V, Belloni A, Sabbatini S, Pro C, Orilisi G, Monterubbianesi R, Tosco V, Byrne HJ, Vaccari L, Giorgini E. Cytotoxic Effects of 5-Azacytidine on Primary Tumour Cells and Cancer Stem Cells from Oral Squamous Cell Carcinoma: An In Vitro FTIRM Analysis. Cells. 10. PMID 34440896 DOI: 10.3390/cells10082127   
2021 Lawal B, Tseng SH, Olugbodi JO, Iamsaard S, Ilesanmi OB, Mahmoud MH, Ahmed SH, Batiha GE, Wu ATH. Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. Cancers. 13. PMID 34439277 DOI: 10.3390/cancers13164124   
2021 Yan Y, Liang Q, Xu Z, Yi Q. Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration. Peerj. 9: e12171. PMID 34616622 DOI: 10.7717/peerj.12171   
2021 Akter R, Najda A, Rahman MH, Shah M, Wesołowska S, Hassan SSU, Mubin S, Bibi P, Saeeda S. Potential Role of Natural Products to Combat Radiotherapy and Their Future Perspectives. Molecules (Basel, Switzerland). 26. PMID 34641542 DOI: 10.3390/molecules26195997   
2021 Elamin YY, Robichaux JP, Carter BW, Altan M, Gibbons DL, Fossella FV, Lam VK, Patel AB, Negrao MV, Le X, Mott FE, Zhang J, Feng L, Blumenschein G, Tsao AS, et al. Poziotinib for Patients With Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101113. PMID 34550757 DOI: 10.1200/JCO.21.01113   
2021 Choi HS, Ko YS, Jin H, Kang KM, Ha IB, Jeong H, Song HN, Kim HJ, Jeong BK. Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro. Molecules (Basel, Switzerland). 26. PMID 34500557 DOI: 10.3390/molecules26175118   
2021 Wu SY, Lin KC, Lawal B, Wu ATH, Wu CZ. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types. Computational and Structural Biotechnology Journal. 19: 4970-4983. PMID 34584637 DOI: 10.1016/j.csbj.2021.08.047   
2021 Bryukhovetskiy I, Kosianova A, Zaitsev S, Pak O, Sharma A, Sharma HS. Glioblastoma: What can we do for these patients today and what will we be able to do in the future? Progress in Brain Research. 265: 99-118. PMID 34560928 DOI: 10.1016/bs.pbr.2021.04.012   
2021 Park SY, Kim JY, Jang GB, Choi JH, Kim JH, Lee CJ, Lee S, Baek JH, Park KK, Kim JM, Chang HJ, Cho NC, Nam JS. Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells. Theranostics. 11: 8755-8770. PMID 34522210 DOI: 10.7150/thno.63446   
2021 Chen J, Mai H, Chen H, Zhou B, Hou J, Jiang DK. Pan-Cancer Analysis Identified as a Potential Biomarker for Multiple Tumor Types. Frontiers in Molecular Biosciences. 8: 693651. PMID 34490347 DOI: 10.3389/fmolb.2021.693651   
2021 Carter BW, Altan M, Shroff GS, Truong MT, Vlahos I. Post-chemotherapy and targeted therapy imaging of the chest in lung cancer. Clinical Radiology. PMID 34538577 DOI: 10.1016/j.crad.2021.08.001   
2021 Sakuma S, Raices M, Borlido J, Guglielmi V, Zhu EYS, D'Angelo MA. Inhibition of Nuclear Pore Complex Formation Selectively Induces Cancer Cell Death. Cancer Discovery. 11: 176-193. PMID 32988961 DOI: 10.1158/2159-8290.CD-20-0581